Green Bioactives Limited (GBL), a pioneering technology company committed to creating sustainable plant-based products, has announced exciting results from a clinical study demonstrating that GBL-Memory 1 can improve memory by up to 10.1%. Recently launched in the UK and Germany, GBL-Memory 1 marks the company’s first foray into the nutraceutical market.

Published in the peer-reviewed journal Food Science and Nutrition, the study offers compelling evidence at a time when the natural product and health supplement industry is seeking solutions to address cognitive decline in an aging population. The prevalence of cognitive impairment, including mild cognitive impairment (MCI) and dementia, increases with age, doubling every five years after the age of 65. It is estimated that 5-7% of individuals aged 60 or older experience significant cognitive decline each year.

The late Gary Loake, Professor of Molecular Plant Sciences at the University of Edinburgh and Chief Scientific Officer at Green Bioactives, led the study exploring the effects of GBL-Memory 1, a unique complex containing L-theanine and Fructooligosaccharides (FOS), over a 30-day period. The research involved 120 healthy participants divided into two groups, with half taking the supplement and the other half taking a placebo. Significant memory improvements were observed in the supplement group.

Using the Clinical Memory Scale, the study assessed various aspects of memory improvement, including directed memory, associative learning, meaningless image recognition, graphic memory, and portrait retrieval. The results indicated notable benefits in total memory among those taking the supplement.

GBL-Memory 1 is Green Bioactives' first product and will be available to consumers through its brand partners. It will launch in Germany under the name Memocentrix in May and then in the UK in June.

Dr. Yuan Li, a co-author of the study, highlighted the significance of these findings: “GBL-Memory 1 represents a significant advancement in the realm of cognitive enhancement, offering a natural and effective solution for individuals looking to optimize their brain health and cognitive performance.”

Dr. David McElroy, CEO of Green Bioactives, expressed his enthusiasm: "We are thrilled to announce the successful clinical validation and launch of Green Bioactives’ innovative GBL-Memory 1 comprising our proprietary blend of L-theanine and Fructooligosaccharides. This milestone underscores our commitment to advancing natural, scientifically backed solutions for better health and well-being. The significant improvements reported across diverse cognitive areas affirms the potential of GBL-Memory 1 to make a meaningful positive impact on enhancing memory and to contribute towards improving overall brain function."

Rudi Neidhardt, who has been taking GBL-Memory 1 for the last nine months, shared his positive experiences: "Since I started using GBL-Memory, I’ve noticed remarkable improvements in my daily life. I can now remember where I left my wallet and keys, and I even recall names from my past with ease. Those changes are only the “Tip of the iceberg,” and it feels like my brain is working better than ten years ago in all areas of recovering and unlocking stored memory. The clarity and confidence this brings are truly life-changing."

Dr. Clara Doran, Senior Clinical Investigator at Scottish Brain Sciences and former General Practitioner praised the study’s findings: “This paper shows encouraging outcomes for the combination of these two plant-based ingredients, L- theanine and FOS. In today’s fast-paced and multi-tasking world, there is a great need to find accessible and natural ways to improve memory, recall, and productivity in healthy adults, and future research regarding these products could help multiple populations, including geriatrics and women suffering from brain fog in menopause.”

‍